123 related articles for article (PubMed ID: 23317632)
1. Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness.
Arnold DM; Lauzier F; Rabbat C; Zytaruk N; Barlow Cash B; Clarke F; Heels-Ansdell D; Guyatt G; Walter SD; Davies A; Cook DJ;
Thromb Res; 2013 Mar; 131(3):204-9. PubMed ID: 23317632
[TBL] [Abstract][Full Text] [Related]
2. Dalteparin versus unfractionated heparin in critically ill patients.
; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
[TBL] [Abstract][Full Text] [Related]
3. Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis.
Cook D; Sinuff T; Zytaruk N; Rabbat C; Lee A; O'Donnell M; Thabane L; Linkins L; Treleaven D; Patel R; Meade M; Crowther M; Marshall JC; Douketis J;
J Crit Care; 2009 Jun; 24(2):168-75. PubMed ID: 19327956
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.
Crowther M; Cook D; Guyatt G; Zytaruk N; McDonald E; Williamson D; Albert M; Dodek P; Finfer S; Vallance S; Heels-Ansdell D; McIntyre L; Mehta S; Lamontagne F; Muscedere J; Jacka M; Lesur O; Kutsiogiannis J; Friedrich J; Klinger JR; Qushmaq I; Burry L; Khwaja K; Sheppard JA; Warkentin TE; ; ;
J Crit Care; 2014 Jun; 29(3):470.e7-15. PubMed ID: 24726205
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis.
Lauzier F; Arnold DM; Rabbat C; Heels-Ansdell D; Zarychanski R; Dodek P; Ashley BJ; Albert M; Khwaja K; Ostermann M; Skrobik Y; Fowler R; McIntyre L; Nates JL; Karachi T; Lopes RD; Zytaruk N; Finfer S; Crowther M; Cook D
Intensive Care Med; 2013 Dec; 39(12):2135-43. PubMed ID: 23942857
[TBL] [Abstract][Full Text] [Related]
6. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
7. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
8. PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan.
Cook D; Meade M; Guyatt G; Walter SD; Heels-Ansdell D; Geerts W; Warkentin TE; Cooper DJ; Zytaruk N; Vallance S; Berwanger O; Rocha M; Qushmaq I; Crowther M
J Crit Care; 2011 Apr; 26(2):223.e1-9. PubMed ID: 21482348
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
10. Bleeding during critical illness: a prospective cohort study using a new measurement tool.
Arnold DM; Donahoe L; Clarke FJ; Tkaczyk AJ; Heels-Ansdell D; Zytaruk N; Cook R; Webert KE; McDonald E; Cook DJ
Clin Invest Med; 2007; 30(2):E93-102. PubMed ID: 17716547
[TBL] [Abstract][Full Text] [Related]
11. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
12. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
Couturaud F; Julian JA; Kearon C
Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
[TBL] [Abstract][Full Text] [Related]
14. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
[TBL] [Abstract][Full Text] [Related]
15. Thromboprophylaxis in medical-surgical critically ill patients.
Crowther MA; Cook DJ
Curr Opin Crit Care; 2008 Oct; 14(5):520-3. PubMed ID: 18787443
[TBL] [Abstract][Full Text] [Related]
16. Bleeding classification in clinical trials: observer variability and clinical relevance.
Graafsma YP; Prins MH; Lensing AW; de Haan RJ; Huisman MV; Büller HR
Thromb Haemost; 1997 Oct; 78(4):1189-92. PubMed ID: 9364983
[TBL] [Abstract][Full Text] [Related]
17. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
18. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.
Rabbat CG; Cook DJ; Crowther MA; McDonald E; Clarke F; Meade MO; Lee KA; Cook RJ
J Crit Care; 2005 Dec; 20(4):357-63. PubMed ID: 16310608
[TBL] [Abstract][Full Text] [Related]
19. Thromboprophylaxis for intensive care patients in Australia and New Zealand: a brief survey report.
Cooper DJ; Bishop N; Cade J; Finfer S; Gallus A; Myburgh J;
J Crit Care; 2005 Dec; 20(4):354-6. PubMed ID: 16310607
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous heparin does not increase postoperative complications in neurosurgical patients: An institutional experience.
Hacker RI; Ritter G; Nelson C; Knobel D; Gupta R; Hopkins K; Marini CP; Barrera R
J Crit Care; 2012 Jun; 27(3):250-4. PubMed ID: 22226424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
